免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

The CLASP III TR CED Study

NCT:NCT07859709 · NOT_YET_RECRUITING

NCT编号NCT07859709
状态NOT_YET_RECRUITING
开始日期2026-10-15
完成时间2033-10-31
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

简要摘要

This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Repair procedure using the PASCAL Precision system.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑